Mineralys Therapeutics, Inc.

Nasdaq:MLYS

Pharmaceutical Preparations·RADNOR, PA

Governanceproxy statements · beneficial ownership

Proxy Statements

4 shown

Filed	Form	Description
4/9/25	DEFA14A	DEFA14A	→
4/9/25	DEF 14A	DEF 14A	→
4/9/24	DEFA14A	DEFA14A	→
4/9/24	DEF 14A	DEF 14A	→

Ownership Filings

40 shown

Filed	Form	Description
3/10/26	4	4	→
3/4/26	3	FORM 3	→
2/20/26	4	4	→
2/20/26	4	4	→
2/20/26	4	4	→
2/20/26	4	4	→
↓